Turning a corner: Private market posts best month in yearsCore private market metrics suggest positive momentum is brewing and investor sentiment is improving
Turning a corner: Private market posts best month in years
Trading
Data
Solutions
Insights
About
Apeel Sciences was founded in 2012 by James Rogers. Apeel Sciences has not officially endorsed a plan to participate in an IPO.
Apeel is an agricultural tech company developing an edible, plant-based coating that can double the lifespan of fresh fruits and vegetables. Per Forge data, Apeel Sciences raised $719.1 million in funding over 11 rounds, with their latest funding being raised on Jun 29, 2022. Key investors include Viking Global Investors, Temasek Holdings, and GIC.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Apeel is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Apeel pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Apeel is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 8/18/2021 | Series E | $250MM raised | $XXX.XX | $XXX.XX |
| 5/26/2020 | Series D | $278.16MM raised | $XXX.XX | $XXX.XX |
| 8/1/2018 | Series C | $78.67MM raised | $XXX.XX | $XXX.XX |
| 12/13/2016 | Series B | $33.22MM raised | $XXX.XX | $XXX.XX |
| 7/1/2015 | Series A | $5.75MM raised | $XXX.XX | $XXX.XX |
| 12/31/2013 | Series Seed | $1.25MM raised | $XXX.XX | $XXX.XX |
